Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winfried Brenner

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Annals of Nuclear Medicine|August 7, 2012
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasiaVera Froeling, Florian Elgeti, Martin H Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2017
Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on <sup>123</sup>I-MIBG SPECT predict the outcome?Julian M M Rogasch, Patrick Hundsdoerfer, Christian Furth, et al.
Academic Radiology|October 6, 2014
Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agentsJan H Rothe, Ines Rudolph, Nadine Rohwer, et al.
Circulation|September 17, 2008
Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardiumVolker Schächinger, Alexandra Aicher, Natascha Döbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study groupKarin Oechsle, Michael Hartmann, Winfried Brenner, et al.
Molecular Oncology|October 5, 2019
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancerGustav Steinemann, Alexandra Dittmer, Jacob Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2014
Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancerFrank Hofheinz, Alexandr Lougovski, Klaus Zöphel, et al.
Scientific Reports|February 5, 2026
Quantification of overall tumor burden using longitudinal magnetic resonance imaging improves response assessment in orthotopic murine hepatocellular carcinoma modelsIsabella Lurje, Wiebke Werner, Nicole Hilbert, et al.
EJNMMI Research|January 20, 2026
Optimizing PET/CT protocols: is 60-minute [18 F]F-FDG uptake sufficient for cardiac sarcoidosis?Giulia Metzger, Bettina Heidecker, Jonas Kaufmann, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Annals of Nuclear Medicine|August 7, 2012
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasiaVera Froeling, Florian Elgeti, Martin H Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2017
Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on <sup>123</sup>I-MIBG SPECT predict the outcome?Julian M M Rogasch, Patrick Hundsdoerfer, Christian Furth, et al.
Academic Radiology|October 6, 2014
Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agentsJan H Rothe, Ines Rudolph, Nadine Rohwer, et al.
Circulation|September 17, 2008
Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardiumVolker Schächinger, Alexandra Aicher, Natascha Döbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study groupKarin Oechsle, Michael Hartmann, Winfried Brenner, et al.
Molecular Oncology|October 5, 2019
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancerGustav Steinemann, Alexandra Dittmer, Jacob Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2014
Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancerFrank Hofheinz, Alexandr Lougovski, Klaus Zöphel, et al.
Scientific Reports|February 5, 2026
Quantification of overall tumor burden using longitudinal magnetic resonance imaging improves response assessment in orthotopic murine hepatocellular carcinoma modelsIsabella Lurje, Wiebke Werner, Nicole Hilbert, et al.
EJNMMI Research|January 20, 2026
Optimizing PET/CT protocols: is 60-minute [18 F]F-FDG uptake sufficient for cardiac sarcoidosis?Giulia Metzger, Bettina Heidecker, Jonas Kaufmann, et al.
Pageof 17